Jul 13–19, 2026 · 1 randomized trial, 5 new studies, 2 reviews · Orthopaedic Oncology archive · All weeks
The new Orthopaedic Oncology research The Reduction sent the week of Jul 13–19, 2026, with the week’s most recent reviews, each with a one-line summary.
Get papers like these by email, free: subscribe to The Reduction, focused on your interests, on the days you pick.
Asian patients showed higher functional outcomes after endoprosthetic reconstruction for bone tumors; women demonstrated greater postoperative improvements than men.
Multicomponent machine learning approach using multiple registries improves osteosarcoma survival prediction accuracy across diverse populations versus single data-set models.
Novel separation surgery with vertebroplasty and iodine-125 seed implantation provides minimally invasive decompression and local control for thoracic metastatic spinal cord compression.
Biological reconstruction of pediatric proximal tibial tumors with allografts showed 56% survival at 5 years and 48% at 10 years despite 57% complication rates.
Preoperative hypoalbuminemia independently predicts 30-day complications, mortality, and non-home discharge in dose-dependent fashion after spinal metastasis surgery.
Random Forest and sparse elastic-net models effectively predict one-month postoperative performance status after spinal metastasis surgery with good discrimination.
Autograft and Biologic Living Bone Reconstructions in Orthopaedic Oncology.
Biological bone autografts provide more durable long-term reconstructions than endoprosthetics but require extended healing time and carry high short-term complication rates.
Updated consensus for recurrent retroperitoneal sarcoma emphasizes histologic type, individualized multidisciplinary treatment, and nomograms for outcome prediction.
← Week of Jul 6–12, 2026Week of Jul 20–26, 2026 →
Home · All weeks · Archive · Subscribe · FAQ
© 2026 The Reduction